Request / Find a Test Tool

The National Genomic Test Directories specify which genomic tests are commissioned by the NHS in England, to be delivered by Genomic Laboratory Hubs.

This tool allows clinical teams to search all of the genomic tests available to patients through the National Testing Directory. From here you can find out more details about each test and information about how to order them. These tests can only be ordered by clinical teams, if you are a patient looking to request a test please speak to your clinical team directly.

Carney complex

Clinical Indication ID & Name

R156

Carney complex

Test Group

Endocrinology

Test code

R156.1

Test name

N/A

Target genes

PRKAR1A

Test scope

n/a

Test method/ technology

Single gene sequencing >=10 amplicons

Optimal Family Structure

n/a

Eligibility Criteria

Two or more of the features from the list below (with histological confirmation where relevant), OR
One feature from the list below (with histological confirmation where relevant) and an affected first degree relative:
• Spotty skin pigmentation with typical distribution (lips, conjunctiva, vaginal and penile mucosa)
• Myxoma (cutaneous and mucosal)
• Cardiac myxomas
• Breast myxomatosis or fat-suppressed MRI suggestive of this finding
• PPNAD or paradoxical positive response of urinary glucocorticosteroid excretion to dexamethasone administration during Liddles test
• Acromegaly due to GH-producing adenoma
• Large cell calcifying Sertoli cell tumour (LDDST) or characteristic calcification on testicular ultrasound
• Thyroid carcinoma or multiple, hypoechoic nodules on thyroid ultrasound in a young patient
• Psammomatous melanotic schwannomas (PMS)
• Blue nevus, epithelioid blue nevus
• Breast ductal adenoma
• Osteochondromyxoma

Test code

Test name

N/A

Target genes

Test scope

n/a

Test method/ technology

n/a

Optimal Family Structure

n/a

Eligibility Criteria

Two or more of the features from the list below (with histological confirmation where relevant), OR
One feature from the list below (with histological confirmation where relevant) and an affected first degree relative:
• Spotty skin pigmentation with typical distribution (lips, conjunctiva, vaginal and penile mucosa)
• Myxoma (cutaneous and mucosal)
• Cardiac myxomas
• Breast myxomatosis or fat-suppressed MRI suggestive of this finding
• PPNAD or paradoxical positive response of urinary glucocorticosteroid excretion to dexamethasone administration during Liddles test
• Acromegaly due to GH-producing adenoma
• Large cell calcifying Sertoli cell tumour (LDDST) or characteristic calcification on testicular ultrasound
• Thyroid carcinoma or multiple, hypoechoic nodules on thyroid ultrasound in a young patient
• Psammomatous melanotic schwannomas (PMS)
• Blue nevus, epithelioid blue nevus
• Breast ductal adenoma
• Osteochondromyxoma

Commissioning group

Specialised

Overlapping idications

n/a

Address for samples/request forms

North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH

Contact with queries

gos-tr.norththamesgenomics@nhs.net

Supporting documents

Rare Disese WGS Clinician pack

Education resources

n/a

Service updates

n/a

Request form download

Consent record

See consent guidance in test request form

Sample requirements

See sample guidance in test request form